🇺🇸 FDA
Patent

US 10023652

Method of targeting glycoproteins to treat cancer

granted A61KA61K2039/505A61K31/282

Quick answer

US patent 10023652 (Method of targeting glycoproteins to treat cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K31/282, A61K31/4745, A61K31/513